Nucleo Life Sciences Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
Nucleo Life Sciences General Information
Description
Developer of pharmaceutical products intended to help patients by developing innovative therapies into commercially viable products. The company offers pre-formulation and formulation development, process development, analytical development, method transfer as well as scale-up services, enabling its clients to take their drugs to the market quickly and effectively.
Contact Information
Website
www.nucleolifesciences.comCorporate Office
- 27 Jordan Street
- San Rafael, CA 94901
- United States
Corporate Office
- 27 Jordan Street
- San Rafael, CA 94901
- United States
Nucleo Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nucleo Life Sciences Comparisons
Industry
Financing
Details
Nucleo Life Sciences Competitors (27)
One of Nucleo Life Sciences’s 27 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Cipla | Corporation | Mumbai, India | ||||
| CSL Behring (Biotechnology) | Corporation | Vienna, Austria | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Pharmaceutics International | Formerly PE-Backed | MD |
Nucleo Life Sciences Signals
Nucleo Life Sciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nucleo Life Sciences FAQs
-
When was Nucleo Life Sciences founded?
Nucleo Life Sciences was founded in 2014.
-
Where is Nucleo Life Sciences headquartered?
Nucleo Life Sciences is headquartered in San Rafael, CA.
-
What is the size of Nucleo Life Sciences?
Nucleo Life Sciences has 13 total employees.
-
What industry is Nucleo Life Sciences in?
Nucleo Life Sciences’s primary industry is Drug Discovery.
-
Is Nucleo Life Sciences a private or public company?
Nucleo Life Sciences is a Private company.
-
What is Nucleo Life Sciences’s current revenue?
The current revenue for Nucleo Life Sciences is .
-
Who are Nucleo Life Sciences’s investors?
MBC BioLabs and QB3 have invested in Nucleo Life Sciences.
-
Who are Nucleo Life Sciences’s competitors?
Ardelyx, Cipla, CSL Behring (Biotechnology), Glenmark Pharmaceuticals, and Pharmaceutics International are some of the 27 competitors of Nucleo Life Sciences.
-
When was Nucleo Life Sciences acquired?
Nucleo Life Sciences was acquired on 24-May-2021.
-
Who acquired Nucleo Life Sciences?
Nucleo Life Sciences was acquired by Bend Bioscience (Formerly CoreRx).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process